Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients

Documenti analoghi

• Identification of a Novel RUNX1::HMGN1 Fusion in Therapy Acute Myeloid Leukemia
  di: Li Fen, et al.
  Pubblicazione: (2025)
• Identification of a Novel RUNX1::STX2 Fusion in Mixed‐Phenotype Acute Leukemia (MPAL) With BCR::ABL1
  di: Yuan Long, et al.
  Pubblicazione: (2024)
• HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction
  di: Xinying Yue, et al.
  Pubblicazione: (2025)
• RUNX1 Directly Activates WNT2 to Orchestrate Tumor‐Associated Macrophage Reprogramming in Colorectal Cancer
  di: Wei Sun, et al.
  Pubblicazione: (2026)
• RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes
  di: Yiran Tao, et al.
  Pubblicazione: (2025)